Back to search

Belgium· BE-AMP-SAM422441-00

Atovaquone/Proguanil EG 250 mg - 100 mg

A proguanil and atovaquone product containing proguanil hydrochloride, registered in Belgium by EG. The same ATC class is registered in 13 of our 19 countries.

ATC P01BB51

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAtovaquone/Proguanil EG 250 mg - 100 …ATCP01BB51REGISTER NO.BE-AMP-SAM422441-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Proguanil and atovaquone is registered in 13 of 19 countries.

Countries holding a registration under ATC P01BB51 (proguanil and atovaquone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Proguanil and atovaquone · ATC P01BB51

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of proguanil and atovaquone costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Proguanil and atovaquone · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.96
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Proguanil Hydrochloride
Manufacturer
EG
Country
Belgium (BE)
ATC code
P01BB51
ATC class
Proguanil and atovaquone
Defined daily dose
0.4 g, Proguanilhydroch
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    3908720
  • be_apb
    3908738
  • be_apb
    3796174

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for proguanil and atovaquone.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Proguanil and atovaquone · interactions on record

40 records

  • 4 severe
  • 27 moderate
  • 3 minor

Most severe, free to view

  • EfavirenzJ05AG03severe
  • Sodium aurothiomalateM01CB01severe
  • AuranofinM01CB03severe
  • AurothioglucoseM01CB04severe

6 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Proguanil and atovaquone in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All proguanil and atovaquone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/67d658dd-540c-448a-9709-b81fc25055e2
GET /v1/drugs/67d658dd-540c-448a-9709-b81fc25055e2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Atovaquone/Proguanil EG 250 mg - 100 mg",
  "name_fr": "Atovaquone/Proguanil EG 250 mg - 100 mg",
  "name_nl": "Atovaquone/Proguanil EG 250 mg - 100 mg",
  "amp_code": "SAM422441-00",
  "strengths": [
    "100.0000",
    "100.0000",
    "250.0000",
    "250.0000",
    "50.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Proguanil Hydrochloride",
    "Atovaquone",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Proguanil and Atovaquone",
  "authorisation_numbers": [
    "BE422441"
  ]
}

See everything about proguanil and atovaquone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.